Navigation Links
Cardiac Science Appoints Peter Kingma Senior Vice President Sales and Marketing
Date:11/11/2009

BOTHELL, Wash., Nov. 11 /PRNewswire-FirstCall/ -- Cardiac Science Corporation (Nasdaq: CSCX), a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, appointed Peter Kingma as senior vice president, effective immediately. In this new role, Mr. Kingma reports to Dave Marver, president and chief executive officer, and oversees the Company's sales, marketing, and service functions.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080306/AQTH510LOGO)

"Our growth plans require that our customer-facing capabilities be outstanding," said Dave Marver, Cardiac Science president and chief executive officer. "We will be launching a series of new products in 2010 that leverage our well-known brands, distribution strength, and large customer base. Peter will help us make the most of those launches and build long-term advantage for the Company through our commercial functions. He also has significant global and business management expertise which will help us fully exploit our many opportunities for international expansion."

Mr. Kingma, 52, worked for Siemens from 1985 to 2008 where he held a number of significant leadership roles in the cardiac technology space. He served as Global Vice President-CT Division in Germany, US Vice President and Business Manager-CT Division, and US Vice President and Business Manager-Molecular Imaging Division. He also served as Managing Director of Siemens Medical Solutions in Australia/New Zealand, and in several senior product and business management roles in Southern Africa. Mr. Kingma has lived and worked in the US, Germany, South Africa, and Australia.

In connection with Mr. Kingma's hiring, the compensation committee of the Company's board of directors approved an inducement grant made outside of the Company's 2002 Equity Incentive Plan pursuant to which Mr. Kingma has been awarded, effective as of close of business on November 16, 2009, a 10-year option to purchase 50,000 shares of common stock of the Company at an exercise price equal to the closing price of the common stock on the Nasdaq Stock Market on the date of grant, with 25 percent of the option to vest after one year of service from the date of grant, and the remaining portion of the option to vest at a rate of 1/36th per month for the next three years thereafter.

Mr. Kingma has an Electrical Engineering (LC) from the Cape Peninsula University of Technology in Cape Town, South Africa and executive business training from the London School of Economics and Duke University's Fuqua School of Business.

About Cardiac Science:

Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AED), electrocardiograph devices (ECG/EKG), cardiac stress test treadmills and systems, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, vital signs monitors, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The company sells a variety of related products and consumables and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick(®), HeartCentrix(®), Powerheart(®), and Quinton(®) brands, is headquartered in Bothell, Washington. With customers in more than 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit http://www.cardiacscience.com.

For updates and information on worldwide defibrillation and cardiac monitoring, find us on the Cardiac Science blog at http://www.cardiacscience.com/blog, Twitter at http://twitter.com/cardiacscience, Facebook at http://budurl.com/CSonFB, YouTube at http://www.youtube.com/user/CardiacScience.

Forward-Looking Statements

This press release contains forward-looking statements. The words "believe," "expect," "intend," "anticipate," variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward-looking. Forward-looking statements in this press release include, but are not limited to, those relating to Cardiac Science Corporation's growth strategies and planned new product launches and the resulting impact on operating results. These are forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause or contribute to such varying results and other risks are more fully described in Cardiac Science Corporation's Annual Report on Form 10-K for the year ended December 31, 2008, as updated by subsequent quarterly reports on Form 10-Q. Cardiac Science Corporation undertakes no duty or obligation to update the information provided herein.

For more information,

    Company Contact:                Investor Contact:     Media Contact:
    Mike Matysik                    Matt Clawson          Christopher Gale
    Cardiac Science Corporation     Allen & Caron         EVC Group Inc.
    Senior Vice President and CFO   949.474.4300          646.201.5431
    425.402.2009                    matt@allencaron.com   203.570.4681
                                                          cgale@evcgroup.com
    CSCX-G

    SOURCE Cardiac Science Corporation


    '/>"/>

SOURCE Cardiac Science Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Cardiac Science Announces Third Quarter Results
2. Boston Scientifics Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan
3. PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument
4. Cardiac Science Appoints Healthcare Executive Ronald A. Andrews, Jr. to Board of Directors
5. Cardiac Science to Present at Third Annual Canaccord Adams Cardiovascular Conference
6. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center First in the United States to Utilize Newly FDA-Cleared CARTO(R) 3 Navigation System
7. Minnesota High School Tournament Sidelines to be More Secure From Sudden Cardiac Arrest
8. HeartSine and Your Safety Company to Donate a Portion of Sales Proceeds to Sudden Cardiac Arrest Foundation
9. Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement
10. Cellular Dynamics International and VivoMedica Launch the CARDIOTOX Consortium to Validate a Human Cardiac Model for Preclinical Cardiotoxicity Testing
11. Video: MADIT-CRT Trial Results Provide Clinical Evidence That Cardiac Resynchronization Therapy Significantly Slows Heart Failure Progression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... 2017   The Accreditation Council for Medical ... in the pharmaceutical industry has appointed Dr. ... newly formed scientific advisory board. Dr. Chin will ... first ever medical affairs think tank within the ... the ACMA, please visit  www.medicalaffairsspecialist.org .  Connect ...
(Date:3/24/2017)... DUBLIN , Mar. 24, 2017 Research and ... (IPF) Pipeline Analysis, 2016" report to their offering. ... The IPF pipeline is very strong with ... Corporation, Merck & Co., Inc., Biogen and Sanofi are involved in the ... candidates, of which one is in Phase III stage, 15 are in ...
(Date:3/24/2017)... , March 24, 2017 Today ... Equipment stocks, which are: Neovasc Inc. (NASDAQ: NVCN), Hologic Inc. ... Inc. (NASDAQ: SSH ). These companies are part ... prior gains on Thursday, March 23 rd , 2017, with ... while shares of health care companies in the S&P 500 ...
Breaking Medicine Technology:
(Date:3/24/2017)... , ... March 24, 2017 , ... The Radiology ... Quest Awards . The annual awards, now in their 12th year, are among the ... the winners. , In 2016, the awards were retooled to recognize achievements in both ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... Premier Center for Shamanic Healing and Spiritual Awakening, proudly presents her Sacred ... 2017. This sacred and spiritual journey during the Summer Solstice will also ...
(Date:3/24/2017)... ... 2017 , ... The law firm of Enea, Scanlan & Sirignano, LLP, ... resident Lauren C. Enea has joined the firm as an associate attorney. Ms. Enea, ... in elder law, Medicaid planning and applications, and Wills, Trusts and Estates. Samantha ...
(Date:3/24/2017)... ... 2017 , ... “Finding Christ Through Social Media: Year One ... the writer’s path toward true communion with God. “Finding Christ Through Social Media: ... creation of published author Lea Michelle Johnson, a follower of Christ, wife and ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... In 2016 ... now estimates that there could be four million Zika-related cases in the Americas within ... with numbers of US cases reported per year skyrocketing to an estimated 329,000. Yet, ...
Breaking Medicine News(10 mins):